Carolina Molecular Inc. is a biotechnology company located in Morrisville, North Carolina, that offers molecular products and services.
Subscribe to see Carolina Molecular Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Carolina Molecular Inc. is a biotechnology company headquartered in Morrisville, United States. Its most recent funding round, Seed, raised $1.1M in September 2025. Xcout tracks 4 named people at Carolina Molecular Inc., including Trent Carrier (President).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $1.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Carolina Molecular Inc.'s closest competitors — see the full list of competitors and alternatives →
CellMosaic, Inc. is a company specializing in bioconjugation and crosslinking technologies. It sells antibody drug conjugate (ADC) kits, AqT® bioconjugate kits and reagents, and crosslinking and labeling products through an online store, and offers services such as custom bioconjugation, ADC and other drug conjugate development and manufacturing, and analytical services.
Hibrigen is a biotechnology company established in 2010 that engages in the production of molecular biotechnology products in Turkey.
McLab, Inc., also known as Molecular Cloning Laboratories (MCLAB), is a biotechnology company based in South San Francisco, California, United States. The company specializes in a wide range of molecular biology services, reagents, and protein engineering products.
GenScript Biotech Corporation was founded in New Jersey in 2002 and accelerates innovation in biotechnology and healthcare. The company provides custom services and products to help researchers and corporate clients advance scientific discovery.
RJH Biosciences develops transfection reagents and nucleic acid delivery systems for various human cells, cell lines, and preclinical animal models. The company serves the biomedical research and development sector by providing tailored products and contract research services for applications such as mRNA, DNA, siRNA, and CRISPR delivery.
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases. Its diverse product line supports critical stages of biopharmaceutical development, featuring nucleic acids for both diagnostic and therapeutic applications, antibody-based solutions for detecting impurities in biopharmaceutical manufacturing, and tools for monitoring protein expression across different tissue types. The company conducts its operations through two distinct segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment specializes in manufacturing and distributing products integral to gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics. This encompasses reagents utilized in the chemical synthesis, modification, labeling, and purification of DNA and RNA. Additionally, this division provides messenger RNA, oligonucleotides, their foundational building blocks, plasmid DNA, and the proprietary CleanCap capping technology. Meanwhile, the Biologics Safety Testing segment offers analytical products vital for developing biologic manufacturing processes. Its offerings include bespoke antibody and assay development services tailored to specific products, alongside HCP ELISA kits, various other ELISA kits for identifying bioprocess impurities and contaminants, ancillary reagents, and custom service solutions. Maravai's clientele spans biopharmaceutical companies, other life sciences and biopharmaceutical research firms, academic research institutions, and in vitro diagnostics companies. Incorporated in 2020, Maravai LifeSciences Holdings, Inc. maintains its headquarters in San Diego, California.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Carolina Molecular Inc.? Suggest a correction · Work at Carolina Molecular Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.